Form 4 for MEDP Medpace Holdings, Inc.
Accepted 2024-05-17 00:00:00 ET · period of report 2024-05-15 · accession 0001668397-24-000103 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-05-17 | 2024-05-15+ | MEDP | Troendle August J. | CEO, Dir, 10% | S - Sale | $404.76 | -39.3K | 675.5K | -6% | -$15.92M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-16 | S | D | 7,060 | $403.09 | 668,413 | D | — | — | (F3) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $400.00 to $407.565. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
| 2 | Common | Common Stock | 2024-05-15 | S | D | 32,282 | $405.13 | 675,473 | D | — | — | (F2) The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $400.00 to $407.70. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |